Notable Labs Price To Sales Ratio Over Time
NTBL Stock | 0.40 0.01 2.56% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Notable Labs Performance and Notable Labs Correlation. Notable |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Notable Labs. If investors know Notable will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Notable Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 0.042 | Return On Assets (1.06) | Return On Equity (4.64) |
The market value of Notable Labs is measured differently than its book value, which is the value of Notable that is recorded on the company's balance sheet. Investors also form their own opinion of Notable Labs' value that differs from its market value or its book value, called intrinsic value, which is Notable Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Notable Labs' market value can be influenced by many factors that don't directly affect Notable Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Notable Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Notable Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Notable Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Notable Labs and related stocks such as Kaiser Aluminum, U Power Limited, and Boiron SA Price To Sales Ratio Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KALU | 0.797 | 0.6691 | 0.867 | 1.0192 | 0.9385 | 1.0335 | 1.0401 | 1.2995 | 0.9338 | 1.1716 | 1.3327 | 0.5674 | 0.3525 | 0.3688 | 0.35 |
UCAR | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 9.6 K | 1.7 K | 1.9 K | 7.9328 | 7.54 |
PCAR | 0.4411 | 0.8323 | 0.9416 | 1.224 | 1.2709 | 0.8793 | 1.3171 | 1.2857 | 0.8535 | 1.0718 | 1.5977 | 1.305 | 1.1964 | 1.4564 | 1.53 |
DAN | 0.416 | 0.2346 | 0.3198 | 0.4243 | 0.5191 | 0.3621 | 0.4756 | 0.6443 | 0.2427 | 0.304 | 0.3969 | 0.3694 | 0.2139 | 0.1999 | 0.22 |
DOOO | 1.0479 | 1.0479 | 1.0479 | 1.0871 | 0.7435 | 0.473 | 0.7118 | 1.1737 | 0.7077 | 1.036 | 1.288 | 1.1457 | 0.8795 | 0.631 | 0.73 |
Notable Labs and related stocks such as Kaiser Aluminum, U Power Limited, and Boiron SA Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Notable Labs stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Notable Labs sales, a figure that is much harder to manipulate than other Notable Labs multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
Notable Labs | NTBL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | Israel |
Exchange | NASDAQ Exchange |
null 0.4
Additional Information and Resources on Investing in Notable Stock
When determining whether Notable Labs is a strong investment it is important to analyze Notable Labs' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Notable Labs' future performance. For an informed investment choice regarding Notable Stock, refer to the following important reports:Check out Notable Labs Performance and Notable Labs Correlation. For more information on how to buy Notable Stock please use our How to buy in Notable Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Notable Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.